Boston Scientific Profit Falls Even as Demand for Its Heart Products Surges - MSN

Boston Scientific Lowers FY EPS Outlook, Raises Adjusted EPS The company now sees full-year EPS to be in a range of $1.28 to $1.30, down from its previous outlook of $1.34 to $1.38. Read More

Boston Scientific lifts earnings forecast on solid demand for heart devices | Reuters

Oct 26 (Reuters) - Boston Scientific (BSX.N), opens new tab raised its annual profit forecast on Thursday, banking on strong demand for heart devices including its stroke prevention product ... Read More

Boston Scientific Profit and Sales Are Boosted by Cardiovascular Device Demand - MSN

Boston Scientific raised its full-year adjusted EPS forecast to a range of $2.38 to $2.42 from its previous outlook of $2.29 to $2.34. It sees revenue growth of 13.5% to 14.5%, up from 11.0% to 13.0%. Read More

UPDATE 3-Boston Scientific lifts earnings forecast on solid demand for heart devices - Yahoo Finance

Oct 26 (Reuters) - Boston Scientific raised its annual profit forecast on Thursday, banking on strong demand for heart devices including its stroke prevention product, Watchman, and a recovery in ... Read More

Boston Scientific Q3 Earnings: Revenue And EPS Beat, Lifts Annual Forecast On Strong Demand For Heart Devices - Boston Scientific (NYSE:BSX) - Benzinga

Boston Scientific reported 29.2% growth for cardiology products and 11.8% growth in peripheral interventions. MedSurg segment revenues increased 10.3% to $1.48 billion (10.4% operationally and 7.7 ... Read More

Boston Scientific sees higher-than-expected 2025 profit on strong demand - Reuters

Feb 5 (Reuters) - Medical device maker Boston Scientific (BSX.N), opens new tab forecast annual profit above Wall Street estimates on Wednesday, banking on steady demand for its heart devices ... Read More

Boston Scientific raises annual profit forecast on heart devices demand

Boston Scientific now expects 2024 adjusted earnings per share in the range of $2.38 to $2.42, compared with its previous forecast range of $2.29 to $2.34 per share. Analysts expect a profit of $2 ... Read More

Boston Scientific Profit Falls Even as Demand for Its Heart Products Surges - Investopedia

EPS came in a penny below expectations at $0.32, while Boston Scientific had predicted a range of $0.36 to $0.38. Adjusted EPS of $0.63 was better than projections and the company's prior guidance. Read More

Boston Scientific Profit and Sales Are Boosted by Cardiovascular Device Demand - Investopedia

Boston Scientific raised its full-year adjusted EPS forecast to a range of $2.38 to $2.42 from its previous outlook of $2.29 to $2.34. It sees revenue growth of 13.5% to 14.5%, up from 11.0% to 13.0%. Read More